ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 13 analysts with an average price target of $10.92. This is a potential upside of $9.81 (883.78%) from yesterday's end of day stock price of $1.11.

Allogene Therapeutics's activity chart (see below) currently has 120 price targets and 122 ratings on display. The stock rating distribution of ALLO is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.99% with an average time for these price targets to be met of 78.4 days.

Highest price target for ALLO is $14, Lowest price target is $5, average price target is $8.76.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 19-Mar-2025. First documented stock forecast 04-Nov-2018.

Currently out of the existing stock ratings of ALLO, 30 are a BUY (83.33%), 6 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$6.84 (589.66%)

$9

1 months 28 days ago
(19-Mar-2025)

0/10 (0%)

$6.31 (373.37%)

Buy

$14

$12.84 (1106.90%)

2 months 3 days ago
(14-Mar-2025)

1/3 (33.33%)

$12.06 (621.65%)

192

Hold

$5

$3.84 (331.03%)

2 months 3 days ago
(14-Mar-2025)

1/9 (11.11%)

$3.06 (157.73%)

148

Buy

$9

$7.84 (675.86%)

$11

6 months 3 days ago
(13-Nov-2024)

2/8 (25%)

$6.54 (265.85%)

3

Buy

$10

$8.84 (762.07%)

$11

6 months 9 days ago
(07-Nov-2024)

0/2 (0%)

$6.92 (224.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 78.4 days on average for the stock forecasts to be realized with a an average price target met ratio 22.99

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 11 price targets and 8 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $30.49

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Asthika Goonewardene with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?